An Assistant Model for IRD Care Needs: A Randomized Control Trial
IRD
A Multi-stage Evaluation Foundation Model for Inherited Retinal Diseases Care Needs: A Randomized Control Trial
2 other identifiers
interventional
300
1 country
2
Brief Summary
we present FM-IRD(also designated as Retina4IRD), the first foundation model-based AI system specifically designed for genotype diagnosis of IRD by emulating clinician decision-making reasoning process. Retina4IRD is capable of processing multimodal input including color fundus photography (CFP), optical coherence tomography (OCT), and descriptive medical metadata. Trained and validated on genetically confirmed cases from centers across China, South Korea, and Poland, the system generates a ranked list of candidate pathogenic genetic variants. Retina4IRD also can generated attention heatmaps to enhance decision-making interpretability. To validate its clinical impact, we conducted a prospective multicenter RCT involving 295 participants, rigorously assessing Retina4IRD's diagnostic accuracy and real-world utility. This will improve the standardized diagnosis of IRD diseases, effectively transforming the traditional time-consuming and resource-intensive diagnostic pathway into an efficient intelligent workflow
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2025
CompletedFirst Posted
Study publicly available on registry
February 21, 2025
CompletedStudy Start
First participant enrolled
February 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedMarch 16, 2026
March 1, 2026
3 months
February 11, 2025
March 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The diagnostic accuracy of IRDs
The top-5 gene mutation prediction accuracy, which will be assessed after all participants of the study have had WES test
21 days
Secondary Outcomes (1)
Quality of the health management strategy
7 days
Study Arms (2)
Retina4IRD(also designated as FM-IRDs) assisted arm
EXPERIMENTALArm A: In the diagnostic process of IRD, retinal specialists make diagnostic decision with the assistance of FM-IRDs.
specialist-only without AI assisted arm
ACTIVE COMPARATORArm B: In the diagnostic process of IRD, retinal specialists make independent decision-making without the assistance of FM-IRDs.
Interventions
A Foundation Model for Assisting the precision Diagnosis of Inherited Retinal Diseases: FM-IRDs
without FM-IRDs
Eligibility Criteria
You may qualify if:
- Presenting with clinical features suggestive of suspected IRD based on the initial assessment by the physician
You may not qualify if:
- Refusal to undergo WES genetic testing.
- Screening for a history of intraocular surgery in both eyes within the past 6 months;
- Subjects with severe systemic diseases, intellectual developmental disorders, psychiatric illnesses, etc.
- Patient data that the investigator deems necessary to exclude.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Shanghai General Hospital, Shanghai Jiao Tong University
Shanghai, 200080, China
Shanghai general hospital
Shanghai, China
Study Officials
- PRINCIPAL INVESTIGATOR
Xiaodong Sun, PhD
Shanhai General Hopsital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 11, 2025
First Posted
February 21, 2025
Study Start
February 27, 2025
Primary Completion
June 7, 2025
Study Completion
July 1, 2025
Last Updated
March 16, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share